This is an aggregated industry headline. Read the full story at Drug Channels →
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx's proprietary data and case studies, Stephen highlights patterns that can undermine patient support program effectiveness. He argues that a more data-driven approach can help manufacture
By Drug Channels
· Jun 5, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
AstraZeneca will pay $34 million to resolve a lawsuit that alleged the company used illegal kickbacks to induc…
The WeekFierceBiotech ↗
Coming on the heels of a $130 million fundraising round just four months ago, bone-focused Angitia Biopharmace…
The WeekBriefing
Norwich Pharmaceuticals wins FDA approval for generic baloxavir marboxil, expanding affordable access to one-d…